GX CG5 (Lamivudine 100 mg)
Pill with imprint GX CG5 is Brown, Capsule-shape and has been identified as Lamivudine 100 mg. It is supplied by Prasco Laboratories.
Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GX CG5
Lamivudine
- Imprint
- GX CG5
- Strength
- 100 mg
- Color
- Brown
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (nrtis)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Prasco Laboratories
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 66993-0478 | Prasco Laboratories |
| 00173-0662 | GlaxoSmithKline |
Related Images for "GX CG5"
More about lamivudine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 4 Reviews
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Consumer resources
- Other brands
- Epivir, Epivir-HBV
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.